Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-concept
Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organisation (CRO), today a...


















